Jim Cramer Says Chevron Is Doing 'Pretty Well,' Will Give This Pharma Giant 'A Chance'
Portfolio Pulse from Avi Kapoor
Jim Cramer discussed several companies on CNBC's 'Mad Money Lightning Round,' highlighting their recent performances and analyst ratings. Core & Main reported upbeat sales but missed earnings estimates slightly. KLA Corporation received a Buy rating from Stifel. Chevron is performing well with a 4% yield and a new MOU for CCS development. Pfizer, after acquiring Seagen, was downgraded by Argus Research. Leidos Holdings received a price target increase from B of A Securities. SFL Corporation posted better-than-expected results, but Cramer warned about overstaying in the stock.
April 01, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Chevron is doing well with a 4% yield and a new MOU for CCS development, indicating strong performance and growth prospects.
The 4% yield and strategic MOU for CCS development highlight Chevron's strong performance and forward-looking growth strategy, likely leading to a positive short-term impact.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
KLA Corporation received a Buy rating and a $685 price target from Stifel, reflecting positive analyst sentiment.
The reaffirmation of a Buy rating and a significant price target suggests strong analyst confidence in KLA, likely leading to a positive short-term impact on the stock.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Leidos Holdings received a price target increase from B of A Securities, indicating strong performance and positive analyst outlook.
The price target increase reflects a positive analyst outlook and strong performance, likely leading to a positive short-term impact on Leidos Holdings' stock.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 85
NEUTRAL IMPACT
Core & Main reported upbeat sales but missed earnings estimates slightly, indicating mixed financial performance.
The positive sales report could support investor confidence, but the missed earnings estimate may temper enthusiasm, leading to a neutral short-term impact.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
SFL Corporation posted better-than-expected Q4 results, but Cramer warned about overstaying, indicating caution despite positive results.
While the better-than-expected Q4 results are positive, Cramer's caution suggests a mixed outlook, leading to a neutral short-term impact on SFL Corporation's stock.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 75
NEGATIVE IMPACT
Pfizer was downgraded by Argus Research from Buy to Hold following its acquisition of Seagen, indicating mixed sentiment.
The downgrade from Buy to Hold following the Seagen acquisition suggests caution from analysts, potentially leading to a negative short-term impact on Pfizer's stock.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85